2020 annual financial data

Sarepta Therapeutics, Inc. 2020 Operating margin

Sarepta Therapeutics, Inc. 2020 operating margin with verified reported values.

Direct answer

Operating margin was -104.46%.

Operating income was -564,163,000 USD and net income was -554,128,000 USD.
Operating cash flow was 107,466,000 USD.

Get free Sarepta Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
540,099,000 USD
Operating income
-564,163,000 USD
Net income
-554,128,000 USD
Operating cash flow
107,466,000 USD